Healthcare provider profile · identity verified

Vasumitha Alamelu, MD

Internal Medicine · GILROY, CA · NPI 1194801613

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	379	125
Losartan Potassium	Losartan Potassium	187	65
Amlodipine Besylate	Amlodipine Besylate	185	69
Levothyroxine Sodium	Levothyroxine Sodium	182	57
Lisinopril	Lisinopril	154	52
Famotidine	Famotidine	142	59
Atenolol	Atenolol	133	45
Hydrochlorothiazide	Hydrochlorothiazide	126	41
Albuterol Sulfate Hfa	Albuterol Sulfate	111	56
Metformin Hcl Er	Metformin Hcl	110	39
Fluticasone Propionate	Fluticasone Propionate	92	47
Simvastatin	Simvastatin	89	31
Trazodone Hcl	Trazodone Hcl	89	27
Gabapentin	Gabapentin	86	32
Metoprolol Succinate	Metoprolol Succinate	76	27
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	69	17
Pantoprazole Sodium	Pantoprazole Sodium	69	27
Sertraline Hcl	Sertraline Hcl	68	25
Alvesco	Ciclesonide	65	27
Rosuvastatin Calcium	Rosuvastatin Calcium	65	26
Metoprolol Tartrate	Metoprolol Tartrate	62	25
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	61	24
Furosemide	Furosemide	60	19
Omeprazole	Omeprazole	60	20
Tramadol Hcl	Tramadol Hcl	54	suppressed
Meloxicam	Meloxicam	49	23
Tizanidine Hcl	Tizanidine Hcl	47	22
Terazosin Hcl	Terazosin Hcl	43	16
Triamcinolone Acetonide	Triamcinolone Acetonide	42	23
Wixela Inhub	Fluticasone Propion/Salmeterol	42	15
Allopurinol	Allopurinol	41	17
Potassium Chloride	Potassium Chloride	41	13
Alendronate Sodium	Alendronate Sodium	39	15
Fluoxetine Hcl	Fluoxetine Hcl	38	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	36	13
Pradaxa	Dabigatran Etexilate Mesylate	36	11
Acyclovir	Acyclovir	32	13
Lorazepam	Lorazepam	32	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	32	14
Jardiance	Empagliflozin	31	11
Lovastatin	Lovastatin	30	11
Glipizide	Glipizide	29	suppressed
Montelukast Sodium	Montelukast Sodium	29	suppressed
Baclofen	Baclofen	28	suppressed
Trospium Chloride	Trospium Chloride	28	12
Ondansetron Hcl	Ondansetron Hcl	27	suppressed
Metformin Hcl	Metformin Hcl	26	suppressed
Ciclopirox	Ciclopirox	25	12
Humulin N	Insulin Nph Human Isophane	25	suppressed
Duloxetine Hcl	Duloxetine Hcl	24	suppressed
Azelastine Hcl	Azelastine Hcl	22	suppressed
Hydralazine Hcl	Hydralazine Hcl	22	suppressed
Pravastatin Sodium	Pravastatin Sodium	22	suppressed
Propranolol Hcl	Propranolol Hcl	22	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	22	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	21	17
Fluocinonide	Fluocinonide	21	11
Glipizide Er	Glipizide	21	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	20	20
Clopidogrel	Clopidogrel Bisulfate	20	suppressed
Metronidazole	Metronidazole	20	11
Nortriptyline Hcl	Nortriptyline Hcl	20	suppressed
Prednisone	Prednisone	20	12
Spironolactone	Spironolactone	20	suppressed
Azithromycin	Azithromycin	19	17
Advair Hfa	Fluticasone Propion/Salmeterol	18	suppressed
Clonazepam	Clonazepam	18	suppressed
Hydrocortisone	Hydrocortisone	18	12
Ibuprofen	Ibuprofen	17	suppressed
Ketoconazole	Ketoconazole	17	suppressed
Estradiol	Estradiol	16	11
Mupirocin	Mupirocin	16	13
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Nystatin	Nystatin	15	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	12
Combivent Respimat	Ipratropium/Albuterol Sulfate	14	suppressed
Donepezil Hcl	Donepezil Hcl	14	suppressed
Spiriva Respimat	Tiotropium Bromide	14	suppressed
Cefadroxil	Cefadroxil	13	12
Chlorhexidine Gluconate	Chlorhexidine Gluconate	13	suppressed
Cyclosporine	Cyclosporine	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	12
Buspirone Hcl	Buspirone Hcl	12	suppressed
Pregabalin	Pregabalin	12	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	11	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error